Literature DB >> 7239556

Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.

F W Ryning, J L Krahenbuhl, J S Remington.   

Abstract

Studies were carried out with mice to explore in vitro the effector function(s) of macrophages from two different anatomical compartments (peritoneal cavity and lungs). The cytotoxic capacity of macrophages was measured by determining their cytostatic and cytocidal effects on EL-4 tumour target cells, and the microbicidal capacity of macrophages was measured by determining their ability to kill or inhibit the intracellular protozoan, Toxoplasma gondii. Neither peritoneal macrophages (PM) nor bronchoalveolar macrophages (BAM) from normal mice were ever microbicidal or cytotoxic. Intravenous treatment with Corynebacterium parvum greatly enhanced (activated) both effector functions of PM but did not activate BAM. Chronic infection with Toxoplasma activated PM throughout the period of observation (greater than 140 days), but the presence of activated BAM was transient and appeared to coincide with the occurrence of an inflammatory response in the lungs.

Entities:  

Mesh:

Year:  1981        PMID: 7239556      PMCID: PMC1458265     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum.

Authors:  M Olivotto; R Bomford
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

3.  Distribution of Toxoplasma gondii, RH strain, in infected mice as determined by the fluorescent antibody technique and the histopathology of toxoplasmosis.

Authors:  S Ito; K Tsunoda; K Suzuki
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1967

4.  Cooperation of immune lymphoid cells with macrophages in tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

5.  Resistance against Cryptococcus conferred by intracellular bacteria and protozoa.

Authors:  L O Gentry; J S Remington
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

6.  Role for the macrophage in acquired immunity to phylogenetically unrelated intracellular organisms.

Authors:  J Ruskin; J S Rengton
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

7.  Aging and the immune response. II. Lymphocyte responsiveness and macrophage activation in Toxoplasma gondii-infected mice.

Authors:  I D Gardner; J S Remington
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

8.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Cytokinetic studies of the effects of activated macrophages on tumor target cells.

Authors:  J L Krahenbuhl; L H Lambert
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  4 in total

1.  Complement-dependent killing of Nippostrongylus brasiliensis infective larvae by rat alveolar macrophages.

Authors:  T G Egwang; J Gauldie; D Befus
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

Review 2.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

3.  Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines.

Authors:  E Brummer; D A Stevens
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

4.  Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.